Uncover the potential of active and passive investing on 6th October at 4pm. Register Now!
you are here: HomeNewscoronavirus
Last Updated : Aug 07, 2020 08:15 AM IST | Source: Moneycontrol.com

Patanjali Ayurved cannot use 'Coronil' trademark, rules Madras HC

The HC order came in a trademark infringement case filed by Chennai-based Ardura Engineering Pvt proceedings against Patanjali Ayurved

The Madras High Court on August 6 ordered Patanjali Ayurved to stop using ‘Coronil’ branding for its 'immunity-boosting' products.

The order came in a trademark infringement case filed by Chennai-based Ardura Engineering Pvt proceedings against Patanjali.

The petitioner claimed that 'Coronil' is a trademark it has owned since 1993. A CNBC-TV18 report stated that the Chennai-based firm also claimed it has rights over ‘Coronil 92-B’ trademark till 2027.


Coronavirus pandemic | Patanjali can't sell Coronil with claims of curing COVID-19: AYUSH Ministry

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

While hearing the case, the Madras HC observed: “The defendants (Patanjali Ayurved) have invited this litigation on themselves. A simple check with the Trade Marks Registry would have revealed that ‘Coronil’ is a registered trademark. If they had, and had still, with audacity, used the name ‘Coronil’, then they deserve no consideration at all.”

The court added: “Patanjali cannot plead ignorance and innocence and seek indulgence.” It also slammed the yoga guru Baba Ramdev’s firm for “exploiting fear and panic among public” despite being a Rs 10 crore company and slapped a fine of Rs 10 lakh on Patanjali.

As per court directions, Patanjali will have to pay the fine to Adyar Cancer Institute and Government Yoga and Naturopathy Medical College by August 21.

The judge said: “Patanjali has been chasing further profits by exploiting the fear and panic among the general public by projecting a cure for the coronavirus, when actually their ‘Coronil tablet’ is not a cure but rather an immunity booster for cough, cold and fever.”

Baba Ramdev had launched Coronil in June as a cure for COVID-19, but had faced immense flak from all quarters for the unverified claims. The AYUSH Ministry had had to step in, and Patanjali was later allowed to sell Coronil only as an immunity booster and not as a COVID-19 medicine.
First Published on Aug 6, 2020 11:09 pm